Reseligo

Medicinal product

(Invented) name

Reseligo

Active substance (s)

Goserelinas

Strength

3,6 mg

Pharmaceutical form

implantas užpildytame švirkšte

Route (s) of administration

leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L02AE03, Goserelin

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-10-02

Date of renewal

Documents

3638_Reseligo 3,6mg_PZ_2026-10-02.docx

3638_Reseligo 3,6mg_PIL_2026-10-02.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Viename implante yra	1 vnt.
Goserelinas	3,6 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122542	108652	1108652	užpildytas švirkštas	N1		Receptinis	LT/L/26/3638/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-10-02	Registruotas